diabetes
-
UAE health authorities approve Sanofi’s Tzield for broader use in type 1 diabetes
The approval expands the use of the therapy to delay the onset of Stage 3 Type 1 diabetes in children as young as one year old.
-
Metabolic collaborates with Dexcom to launch UAE type 2 diabetes CGM study
The study will use the Dexcom G7 Continuous Glucose Monitoring system, developed by a global leader in CGM technology, to assess whether continuous monitoring can improve blood sugar control when integrated into a structured, multidisciplinary care programme.
-
Saudi Ministry of Health collaborates with Boston Scientific on Walk Safe initiative to reduce diabetic amputations
The collaboration follows the signing of a Memorandum of Understanding and forms part of Saudi Arabia’s broader efforts to enhance preventive healthcare and improve outcomes for people living with chronic diseases.
-
Insulet launches EVOLVE trial for fully closed-loop type 2 diabetes system
Insulet received Investigational Device Exemption approval from the U.S. Food and Drug Administration in March 2026, clearing the way for the trial to begin.
-
Insulet introduces Omnipod 5 insulin delivery system to Middle East markets
The Omnipod 5 System streamlines diabetes care through automated insulin adjustments every five minutes, eliminating the burden of multiple daily injections.